Little is known of the mechanisms of this control; however, the alterations in distribution and function of CD4+CD25high regulatory T cells in autoimmune and rheumatic diseases suggest a role for the therapeutic use of these cells. The gene discussed is CD4; the disease is rheumatic disorder.